YOUR CHILD’S MEDICINE AT A GLANCE
To make the most of this medicine, adhere to the prescribed dose, time, and way while giving this medicine to your child. Give it to your child orally, preferably after meals as this will prevent the chance of developing an upset stomach. If your child vomits within 30 minutes of taking Ibugesic Plus Oral Suspension Orange, give the same dose again. In case it is already time for the next dose, skip repeating it. Never give more than the recommended dose for fast relief as that may cause unwanted effects in your child.
Your child may exhibit side effects like nausea, vomiting, stomach pain, heartburn, and diarrhea after taking this medicine. These side effects are temporary and should subside once your child’s body adapts to the medicine. In case they persist or become bothersome for your child, do consult your child’s doctor on a priority basis.
Before giving Ibugesic Plus Oral Suspension Orange to your child, do inform your child’s doctor if your child is allergic to any medicine or products, or has any history of heart problems, birth defects, liver disease, kidney disease, lung disease, or bleeding disorder. This information is critical for dose alteration and helps in planning your child’s overall treatment.
BENEFITS OF IBUGESIC PLUS ORAL SUSPENSION ORANGE FOR YOUR CHILD
In Pain relief
Take it as it is prescribed to get the most benefit. Do not take too much as this can be dangerous and do not take it for longer than you need it. In general, you should take the lowest dose that works, for the shortest possible time.
SIDE EFFECTS OF IBUGESIC PLUS ORAL SUSPENSION ORANGE IN CHILDREN
Common side effects of Ibugesic Plus
- Abdominal pain
HOW CAN I GIVE IBUGESIC PLUS ORAL SUSPENSION ORANGE TO MY CHILD?
HOW IBUGESIC PLUS ORAL SUSPENSION WORKS
Use of Ibugesic Plus Oral Suspension Orange is not recommended in patients with severe kidney disease. Long term use of this medicine can affect the kidney function.
However, the use of Ibugesic Plus Oral Suspension Orange is not recommended in patients with severe liver disease and active liver disease.